Aeterna Zentaris to Present at 7th Annual JMP Securities Healthcare Conference in New York

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\n\n\n\n\nQUÉBEC CITY, July 5, 2012 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:\n AEZS) (TSX: AEZ) (the \"Company\") today announced that its President and\n CEO, Juergen Engel, PhD, will be presenting a corporate overview at the\n 7th Annual JMP Securities Healthcare Conference on Thursday, July 12, 2012,\n at 10:30 am (Eastern), in the Gramercy South Room of the Peninsula\n Hotel in New York City.\n\n\nA live webcast of this presentation will be available on Aeterna\n Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the webcast will also be\n available on the Company's website for a period of 90 days.\n\n\nAbout Aeterna Zentaris \n\n\nAeterna Zentaris is an oncology and endocrinology drug development\n company currently investigating treatments for various unmet medical\n needs. The Company's pipeline encompasses compounds at all stages of\n development, from drug discovery through to marketed products. For more\n information please visit www.aezsinc.com.\n\n\n Investor Relations Ginette Beaudet Vallières Investor Relations Coordinator (418) 652-8525 ext. [email protected] Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext. [email protected] \n","length":1520,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.